Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.

Poupon L, Lamoine S, Pereira V, Barriere DA, Lolignier S, Giraudet F, Aissouni Y, Meleine M, Prival L, Richard D, Kerckhove N, Authier N, Balayssac D, Eschalier A, Lazdunski M, Busserolles J.

Neuropharmacology. 2018 Sep 15;140:43-61. doi: 10.1016/j.neuropharm.2018.07.026. Epub 2018 Jul 26.


Inhibition of somatosensory mechanotransduction by annexin A6.

Raouf R, Lolignier S, Sexton JE, Millet Q, Santana-Varela S, Biller A, Fuller AM, Pereira V, Choudhary JS, Collins MO, Moss SE, Lewis R, Tordo J, Henckaerts E, Linden M, Wood JN.

Sci Signal. 2018 Jun 19;11(535). pii: eaao2060. doi: 10.1126/scisignal.aao2060.


Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene-targeted mice.

Kanellopoulos AH, Koenig J, Huang H, Pyrski M, Millet Q, Lolignier S, Morohashi T, Gossage SJ, Jay M, Linley JE, Baskozos G, Kessler BM, Cox JJ, Dolphin AC, Zufall F, Wood JN, Zhao J.

EMBO J. 2018 Feb 1;37(3):427-445. doi: 10.15252/embj.201796692. Epub 2018 Jan 15.


Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.

Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E, Bourdier G, Bennis K, Lesage F, Eschalier A, Busserolles J, Ducki S.

J Med Chem. 2017 Feb 9;60(3):1076-1088. doi: 10.1021/acs.jmedchem.6b01285. Epub 2017 Jan 20.


New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical Perspectives.

Lolignier S, Gkika D, Andersson D, Leipold E, Vetter I, Viana F, Noël J, Busserolles J.

J Neurosci. 2016 Nov 9;36(45):11435-11439. Review.


[The Nav1.9 channel is crucial for sensing noxious cold].

Lolignier S, Eschalier A, Bonnet C, Delmas P, Busserolles J.

Med Sci (Paris). 2016 Feb;32(2):162-5. doi: 10.1051/medsci/20163202009. Epub 2016 Mar 2. French. No abstract available.


Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.

Minett MS, Pereira V, Sikandar S, Matsuyama A, Lolignier S, Kanellopoulos AH, Mancini F, Iannetti GD, Bogdanov YD, Santana-Varela S, Millet Q, Baskozos G, MacAllister R, Cox JJ, Zhao J, Wood JN.

Nat Commun. 2015 Dec 4;6:8967. doi: 10.1038/ncomms9967.


Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.

Koenig J, Werdehausen R, Linley JE, Habib AM, Vernon J, Lolignier S, Eijkelkamp N, Zhao J, Okorokov AL, Woods CG, Wood JN, Cox JJ.

PLoS One. 2015 Jun 2;10(6):e0128830. doi: 10.1371/journal.pone.0128830. eCollection 2015.


The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.

Lolignier S, Bonnet C, Gaudioso C, Noël J, Ruel J, Amsalem M, Ferrier J, Rodat-Despoix L, Bouvier V, Aissouni Y, Prival L, Chapuy E, Padilla F, Eschalier A, Delmas P, Busserolles J.

Cell Rep. 2015 May 19;11(7):1067-78. doi: 10.1016/j.celrep.2015.04.027. Epub 2015 May 7.


Mechanical allodynia.

Lolignier S, Eijkelkamp N, Wood JN.

Pflugers Arch. 2015 Jan;467(1):133-9. doi: 10.1007/s00424-014-1532-0. Epub 2014 May 22. Review.


Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.

Paterson K, Lolignier S, Wood JN, McMahon SB, Bennett DL.

Ann Neurol. 2014 Apr;75(4):591-6. doi: 10.1002/ana.24122. Epub 2014 Mar 13.


Activation of TREK-1 by morphine results in analgesia without adverse side effects.

Devilliers M, Busserolles J, Lolignier S, Deval E, Pereira V, Alloui A, Christin M, Mazet B, Delmas P, Noel J, Lazdunski M, Eschalier A.

Nat Commun. 2013;4:2941. doi: 10.1038/ncomms3941.


Nav1.9 channel contributes to mechanical and heat pain hypersensitivity induced by subacute and chronic inflammation.

Lolignier S, Amsalem M, Maingret F, Padilla F, Gabriac M, Chapuy E, Eschalier A, Delmas P, Busserolles J.

PLoS One. 2011;6(8):e23083. doi: 10.1371/journal.pone.0023083. Epub 2011 Aug 12.


Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.

Chassain C, Bielicki G, Durand E, Lolignier S, Essafi F, Traoré A, Durif F.

J Neurochem. 2008 May;105(3):874-82. Epub 2007 Dec 13.

Supplemental Content

Loading ...
Support Center